Third, we did not run CARWL group-specific correlations with other immune-inflammation and cachexia indicators such as blood-borne platelets, neutrophils, monocytes, lymphocytes, and chemokines like interleukin-6, which could have disclosed the precise mechanisms underlying the novel CARWL score and the survival outcomes of stage IIIC NSCLC patients. Here, IL6 is linked to non-small cell lung carcinoma.